TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

TRUMY

Terumo Corp ADR

PINKCommon Stock
$13.71
-1.08%today

No SEC filings for this security

Terumo Corp ADR is a foreign or OTC-listed security (PINK) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$12.12 – $18.64
12.1252-week18.64
Market cap
$20.2B
Volume
5.12K
1Y return
-25.23%
Beta
0.23

Price · 1Y

$13.71▼ -25.23%
over 1Y
L $12.12H $18.64

Recent news

market news →
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast CancerBullish
finance.yahoo.com· 2026-06-23
Terumo (TSE:4543) Valuation Check After Strong 2026 Earnings And Sharp Share Price ReboundBullish
finance.yahoo.com· 2026-05-25
Why Terumo (TSE:4543) Is Up 24.5% After Stronger Full-Year Earnings Lift Profitability - And What's NextBullish
finance.yahoo.com· 2026-05-25
Oil, China Economic Reports Damp Asian Stock Markets
finance.yahoo.com· 2026-05-18
OrganOx Announces Appointment of Naoya Iwata as CEO & PresidentBullish
finance.yahoo.com· 2026-05-14
Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and TerumoBullish
finance.yahoo.com· 2026-05-13
Cardiogenic Shock Analysis Report 2026: Market to Reach $5.2 Billion by 2030, Driven by Minimally Invasive Techniques, AI Adoption. and Aging PopulationsBullish
globenewswire.com· 2026-05-07
Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. BraunBullish
finance.yahoo.com· 2026-04-23

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.